Urinary Tract Malignancies - Clinical Medicine

Explore the pathophysiology, diagnosis, and treatment of the two most significant urinary tract malignancies in this comprehensive clinical medicine lecture. Begin with renal cell carcinoma (RCC), examining its epidemiology and major risk factors including smoking, obesity, hypertension, and genetic syndromes like von Hippel-Lindau disease. Learn to recognize the hallmark clinical triad of hematuria, flank pain, and abdominal mass, along with paraneoplastic syndromes such as polycythemia, hypercalcemia, and hepatic dysfunction. Master the diagnostic evaluation process using CT and MRI imaging, and understand the histopathologic subtypes including clear cell, papillary, and chromophobe RCC. Transition to bladder cancer, focusing on its strong association with smoking, aromatic amine exposure, and chronic inflammation from conditions like schistosomiasis. Identify common presentations including painless gross hematuria, urinary frequency, urgency, and dysuria. Study the diagnostic approach utilizing cystoscopy, urine cytology, and imaging while distinguishing between non-muscle-invasive and muscle-invasive disease. Examine the histologic emphasis on urothelial carcinoma and variants including squamous cell and adenocarcinoma. Compare management strategies for both malignancies, covering surgical resection, systemic therapy, immunotherapy, and intravesical treatments for bladder cancer. Understand prognostic factors, recurrence risks, and surveillance protocols to develop a comprehensive clinical understanding of urinary tract malignancies.